PURPOSE: To investigate differences in patient-reported outcome after anterior cruciate ligament (ACL) reconstruction between patients with and without a concomitant full-thickness cartilage lesion. METHODS: 30 primary ACL-reconstructed patients with an isolated concomitant full-thickness cartilage lesion and 59 matched controls without cartilage lesions were identified in the Norwegian National Knee Ligament Registry and included in the present study. The Knee Injury and Osteoarthritis Outcome Score (KOOS) was used as the outcome measure. At a median follow-up of 2.1 years (range, 2-5 years) after ACL reconstruction, 80 (90%) of the patients completed the KOOS. RESULTS: Preoperatively, there were no differences in KOOS between the study group and the control group. At follow-up, patients with full-thickness cartilage lesions reported significantly decreased scores compared to patients without cartilage lesions in the KOOS subscales pain (mean difference, 8.1; 95% confidence interval [CI], 0.8-15.3), activities in daily living (mean difference, 5.8; 95% CI, 0.3-11.2), sport/recreation (mean difference, 19.8; 95% CI, 5.3-34.3) and quality of life (mean difference, 17.2; 95% CI, 4.2-30.1). Patients with full-thickness cartilage lesions reported significantly less improvement from preoperative to follow-up than patients without cartilage lesions for the KOOS subscales pain (mean difference, 11.6; 95% CI, 3.2-19.9), sport/recreation (mean difference, 20.6; 95% CI, 8.1-33.1) and quality of life (mean difference, 16.3; 95% CI, 3.8-28.7). CONCLUSIONS: ACL-injured patients with full-thickness cartilage lesions reported worse outcomes and less improvement after ACL reconstruction than those without cartilage lesions at 2-5 years follow-up. LEVEL OF EVIDENCE: Prognostic; prospective cohort study, Level I.
PURPOSE: To investigate differences in patient-reported outcome after anterior cruciate ligament (ACL) reconstruction between patients with and without a concomitant full-thickness cartilage lesion. METHODS: 30 primary ACL-reconstructed patients with an isolated concomitant full-thickness cartilage lesion and 59 matched controls without cartilage lesions were identified in the Norwegian National Knee Ligament Registry and included in the present study. The Knee Injury and Osteoarthritis Outcome Score (KOOS) was used as the outcome measure. At a median follow-up of 2.1 years (range, 2-5 years) after ACL reconstruction, 80 (90%) of the patients completed the KOOS. RESULTS: Preoperatively, there were no differences in KOOS between the study group and the control group. At follow-up, patients with full-thickness cartilage lesions reported significantly decreased scores compared to patients without cartilage lesions in the KOOS subscales pain (mean difference, 8.1; 95% confidence interval [CI], 0.8-15.3), activities in daily living (mean difference, 5.8; 95% CI, 0.3-11.2), sport/recreation (mean difference, 19.8; 95% CI, 5.3-34.3) and quality of life (mean difference, 17.2; 95% CI, 4.2-30.1). Patients with full-thickness cartilage lesions reported significantly less improvement from preoperative to follow-up than patients without cartilage lesions for the KOOS subscales pain (mean difference, 11.6; 95% CI, 3.2-19.9), sport/recreation (mean difference, 20.6; 95% CI, 8.1-33.1) and quality of life (mean difference, 16.3; 95% CI, 3.8-28.7). CONCLUSIONS: ACL-injured patients with full-thickness cartilage lesions reported worse outcomes and less improvement after ACL reconstruction than those without cartilage lesions at 2-5 years follow-up. LEVEL OF EVIDENCE: Prognostic; prospective cohort study, Level I.
Authors: Jan Harald Røtterud; Einar A Sivertsen; Magnus Forssblad; Lars Engebretsen; Asbjørn Årøen Journal: Am J Sports Med Date: 2011-07 Impact factor: 6.202
Authors: Kurt P Spindler; Todd A Warren; J Claiborne Callison; Michelle Secic; Sheryl B Fleisch; Rick W Wright Journal: J Bone Joint Surg Am Date: 2005-08 Impact factor: 5.284
Authors: Susan L Keays; Peter A Newcombe; Joanne E Bullock-Saxton; Margaret I Bullock; Anthony C Keays Journal: Am J Sports Med Date: 2010-01-05 Impact factor: 6.202
Authors: Karen K Briggs; Jack Lysholm; Yelverton Tegner; William G Rodkey; Mininder S Kocher; J Richard Steadman Journal: Am J Sports Med Date: 2009-03-04 Impact factor: 6.202
Authors: Volker Musahl; Sebastian Kopf; Stephen Rabuck; Roland Becker; Willem van der Merwe; Stefano Zaffagnini; Freddie H Fu; Jon Karlsson Journal: Knee Surg Sports Traumatol Arthrosc Date: 2011-12-30 Impact factor: 4.342
Authors: Asbjørn Arøen; Einar Andreas Sivertsen; Christian Owesen; Lars Engebretsen; Lars Petter Granan Journal: Knee Surg Sports Traumatol Arthrosc Date: 2012-07-17 Impact factor: 4.342
Authors: Kate E Webster; Julian A Feller; Alexander Kimp; Brian M Devitt Journal: Knee Surg Sports Traumatol Arthrosc Date: 2018-03-07 Impact factor: 4.342
Authors: Alexander H King; Aaron J Krych; Matthew R Prince; Paul L Sousa; Michael J Stuart; Bruce A Levy Journal: Knee Surg Sports Traumatol Arthrosc Date: 2015-06-14 Impact factor: 4.342
Authors: Charles L Cox; Laura J Huston; Warren R Dunn; Emily K Reinke; Samuel K Nwosu; Richard D Parker; Rick W Wright; Christopher C Kaeding; Robert G Marx; Annunziata Amendola; Eric C McCarty; Kurt P Spindler Journal: Am J Sports Med Date: 2014-03-19 Impact factor: 6.202
Authors: Lars-Petter Granan; Maria C S Inacio; Gregory B Maletis; Tadashi T Funahashi; Lars Engebretsen Journal: Acta Orthop Date: 2012-11-01 Impact factor: 3.717
Authors: Robert H Brophy; Laura J Huston; Isaac Briskin; Annunziato Amendola; Charles L Cox; Warren R Dunn; David C Flanigan; Morgan H Jones; Christopher C Kaeding; Robert G Marx; Matthew J Matava; Eric C McCarty; Richard D Parker; Armando F Vidal; Michelle L Wolcott; Brian R Wolf; Rick W Wright; Kurt P Spindler Journal: Am J Sports Med Date: 2021-07-29 Impact factor: 7.010